Is Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen? Is Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen safe for nursing mother and child? Does Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen extracts into breast milk? Does Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen has any long term or short term side effects on infants? Can Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen influence milk supply or can Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen decrease milk supply in lactating mothers?

Information in this record refers to the use of Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen as a diagnostic agent. No information is available on the use of Indate(2-)-111In, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen during breastfeeding. [1][2][3] Because of the long half-life of indium 111 and the potential for serious adverse reactions in nursing infants, it is best to avoid the drug in women who wish to continue breastfeeding. If the drug is given, breastfeeding should be discontinued.